Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Chiroscience reports PDE/TNF inhibitors

July 30, 1997

Sepracor reports promising phase II results for norastemizole

July 29, 1997

Genelabs and UCSF sign agreement for asthma clinical study

July 28, 1997

FDA health advisory for Accolate

July 25, 1997

Piperidone and glutarimide neurokinin antagonists developed at Pfizer

July 25, 1997

Antiallergic and bronchodilating effects of KF-19514 in guinea pigs

July 21, 1997

NK3/NK2 receptor antagonists from SmithKline Beecham

July 21, 1997

SmithKline Beecham discloses selective, nonpeptide NK3 antagonists

July 21, 1997

Eisai discloses acridone antiallergy agents

July 18, 1997

Leukotriene antagonists prepared by Leo

July 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...